Association Between First- and Third-Month Responses to Intravitreal Ranibizumab for Diabetic Macular Edema.
Diego Alejandro Valera-CornejoRomero-Morales VeronicaMarlon García-RoaPaulina Ramírez-NeriaYolanda Villalpando-GómezRenata García-FrancoPublished in: Journal of vitreoretinal diseases (2020)
= .032).